Kircher DA, Parkman GL, Fischer GM, Stehn C, Grossmann AH, Boucher K, McMahon M, Davies MA , Mendoza MC, VanBrocklin MW, Holmen S
Factors Influencing Clearance Body Weight: Individuals with higher body masses may process the medication slightly differently, though usually not enough to require dose adjustments
26 luglio 2019 [citato 5 giugno 2024];2(4):e00082
After consulting with a weight loss physician, I hesitantly started taking a glucagon-like peptide-1 (GLP-1) receptor agonist (Zepbound, in my case) approximately two years ago, and, in short, its been life-changing for me in the best way
Actual dosing should always follow provider instructions
Brand GLP-1 weight-loss pens are not part of its lineup